167 related articles for article (PubMed ID: 21140258)
1. Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.
Mendelson JE; Coyle JR; Lopez JC; Baggott MJ; Flower K; Everhart ET; Munro TA; Galloway GP; Cohen BM
Psychopharmacology (Berl); 2011 Apr; 214(4):933-9. PubMed ID: 21140258
[TBL] [Abstract][Full Text] [Related]
2. Acute and post-acute behavioral and psychological effects of salvinorin A in humans.
Addy PH
Psychopharmacology (Berl); 2012 Mar; 220(1):195-204. PubMed ID: 21901316
[TBL] [Abstract][Full Text] [Related]
3. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.
MacLean KA; Johnson MW; Reissig CJ; Prisinzano TE; Griffiths RR
Psychopharmacology (Berl); 2013 Mar; 226(2):381-92. PubMed ID: 23135605
[TBL] [Abstract][Full Text] [Related]
4. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.
Johnson MW; MacLean KA; Reissig CJ; Prisinzano TE; Griffiths RR
Drug Alcohol Depend; 2011 May; 115(1-2):150-5. PubMed ID: 21131142
[TBL] [Abstract][Full Text] [Related]
5. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.
Johnson MW; MacLean KA; Caspers MJ; Prisinzano TE; Griffiths RR
J Psychopharmacol; 2016 Apr; 30(4):323-9. PubMed ID: 26880225
[TBL] [Abstract][Full Text] [Related]
6. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham CW; Rothman RB; Prisinzano TE
Pharmacol Rev; 2011 Jun; 63(2):316-47. PubMed ID: 21444610
[TBL] [Abstract][Full Text] [Related]
7. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
Piekielna J; Fichna J; Janecka A
Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
[TBL] [Abstract][Full Text] [Related]
8. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
9. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.
Ranganathan M; Schnakenberg A; Skosnik PD; Cohen BM; Pittman B; Sewell RA; D'Souza DC
Biol Psychiatry; 2012 Nov; 72(10):871-9. PubMed ID: 22817868
[TBL] [Abstract][Full Text] [Related]
10. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.
Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
Psychopharmacology (Berl); 2005 May; 179(3):551-8. PubMed ID: 15682306
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.
Baker LE; Panos JJ; Killinger BA; Peet MM; Bell LM; Haliw LA; Walker SL
Psychopharmacology (Berl); 2009 Apr; 203(2):203-11. PubMed ID: 19153716
[TBL] [Abstract][Full Text] [Related]
12. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
Cruz A; Domingos S; Gallardo E; Martinho A
Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
[TBL] [Abstract][Full Text] [Related]
13. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
[TBL] [Abstract][Full Text] [Related]
14. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
[TBL] [Abstract][Full Text] [Related]
15. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
Shirota O; Nagamatsu K; Sekita S
J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
[TBL] [Abstract][Full Text] [Related]
16. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
[TBL] [Abstract][Full Text] [Related]
17. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
Butelman ER; Harris TJ; Kreek MJ
Psychopharmacology (Berl); 2004 Mar; 172(2):220-4. PubMed ID: 14586540
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
[TBL] [Abstract][Full Text] [Related]
19. Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid.
Butelman ER; Prisinzano TE; Deng H; Rus S; Kreek MJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):588-97. PubMed ID: 19001155
[TBL] [Abstract][Full Text] [Related]
20. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
